Retinoblastoma Diagnosis to Management
Intravitreal chemotherapy in retinoblastoma
Publication
, Chapter
Semenova, E; Fernandez, JP; Fam, A; Materin, MA
August 30, 2022
The chapter describes intravitreal chemotherapy for treatment of retinoblastoma, including historical aspects, currently used medications, injection protocols, efficacy, side effects and alternatives.
Duke Scholars
Publication Date
August 30, 2022
Start / End Page
189 / 198
Citation
APA
Chicago
ICMJE
MLA
NLM
Semenova, E., Fernandez, J. P., Fam, A., & Materin, M. A. (2022). Intravitreal chemotherapy in retinoblastoma. In Retinoblastoma Diagnosis to Management (pp. 189–198).
Semenova, E., J. P. Fernandez, A. Fam, and M. A. Materin. “Intravitreal chemotherapy in retinoblastoma.” In Retinoblastoma Diagnosis to Management, 189–98, 2022.
Semenova E, Fernandez JP, Fam A, Materin MA. Intravitreal chemotherapy in retinoblastoma. In: Retinoblastoma Diagnosis to Management. 2022. p. 189–98.
Semenova, E., et al. “Intravitreal chemotherapy in retinoblastoma.” Retinoblastoma Diagnosis to Management, 2022, pp. 189–98.
Semenova E, Fernandez JP, Fam A, Materin MA. Intravitreal chemotherapy in retinoblastoma. Retinoblastoma Diagnosis to Management. 2022. p. 189–198.
Publication Date
August 30, 2022
Start / End Page
189 / 198